Patent Yard Sign in
Canadian application, no grantCanada

Compositions comprising epothilones and their use for the treatment of carcinoid syndrome

CA 2468994 A1 · Owner: Rubin, Eric Howard · Inventors: Rothermel, John David; Rubin, Eric Howard

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Use of a compound of formula (I) wherein A represents O or NRN wherein RN is , hydrogen or lower alkyl R is hydrogen or lower alkyl, R' is methyl methoxy, ethoxy, amino, methylamino, dimethylamino aminomethyl or methylthio, and Z is , O or a bond or a pharmaceutically acceptable salt thereof alone or in , combination with at least one compound selected from the group consisting of somatostatin or a synthetic derivative thereof interferon- 5-fluorouracil, doxorubicin cyclophosphamide, streptozotocin and a standard anti-diarrheal for the preparation of a medicament for the treatment of carcinoid syndrome or at least one neuroendocrine tumor; a method of treating a warm-blooded animal having …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed December 12, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 12, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 12, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledDecember 12, 2002
GrantedNo grant recorded
Term endedDecember 12, 2022
Patent numberCA 2468994 A1
Classification (IPC)A61K31/42 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedDec 12, 2002Term endedDec 12, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.